
Bristol Myers Squibb
LEI HLYYNH7UQUORYSJQCN42, SWIFT BMYPUS33XXX
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Profile
|
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
|
General information
-
Organization nameBristol-Myers Squibb Company
-
Organization statusOperating organization
-
AddressC/O The Corporation Trust Company Corporation Trust Center 1209 Orange Street Wilmington, USA, 19801
-
Site
-
IR Site
News
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Stocks
General information
-
Organization nameBristol-Myers Squibb Company
-
Organization statusOperating organization
-
AddressC/O The Corporation Trust Company Corporation Trust Center 1209 Orange Street Wilmington, USA, 19801
-
Site
-
IR Site
Codes
-
LEIHLYYNH7UQUORYSJQCN42
-
SWIFTBMYPUS33XXX
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
ICB4,500 Health Care
-
CIK0000014272
-
EIN22-0790350









